Leal T, et al. Identifying resistance to immune checkpoint inhibitors by screening for PD-L1 and MHC I expression on CTCS in pts with NSCLC. IASLC 2018; abstract P3.04-08.
Immuuntherapie ook in de echte wereld succesvol bij gevorderd merkelcelcarcinoom
dec 2020 | Dermato-oncologie, Immuuntherapie